Cardiovascular Outcome

Also known as: Cardiovascular Outcomes

Drug	Drug Name	Drug Description
DB00175	Pravastatin	An HMG-CoA reductase inhibitor used to lower lipid levels and to reduce the risk of cardiovascular events, including myocardial infarction and stroke.

Drug	Drug Name	Target	Type
DB00175	Pravastatin	3-hydroxy-3-methylglutaryl-coenzyme A reductase	target
DB00175	Pravastatin	Solute carrier organic anion transporter family member 2B1	transporter
DB00175	Pravastatin	P-glycoprotein 1	transporter
DB00175	Pravastatin	Solute carrier organic anion transporter family member 1A2	transporter
DB00175	Pravastatin	Solute carrier family 22 member 6	transporter
DB00175	Pravastatin	Solute carrier family 22 member 8	transporter
DB00175	Pravastatin	Canalicular multispecific organic anion transporter 1	transporter
DB00175	Pravastatin	Solute carrier family 22 member 11	transporter
DB00175	Pravastatin	ATP-binding cassette sub-family G member 2	transporter
DB00175	Pravastatin	Solute carrier family 22 member 7	transporter
DB00175	Pravastatin	Solute carrier organic anion transporter family member 1B1	transporter
DB00175	Pravastatin	Monocarboxylate transporter 1	transporter
DB00175	Pravastatin	Bile salt export pump	transporter
DB00175	Pravastatin	Solute carrier organic anion transporter family member 1B3	transporter
DB00175	Pravastatin	Histone deacetylase 2	target

Drug	Drug Name	Phase	Status	Count
DB00091	Cyclosporine	4	Withdrawn	1
DB00688	Mycophenolate mofetil	4	Withdrawn	1
DB01024	Mycophenolic acid	4	Withdrawn	1
DB00627	Niacin	4	Completed	1
DB00635	Prednisone	4	Withdrawn	1